Breast Cancer Research and Treatment

, Volume 100, Issue 2, pp 183–190 | Cite as

Economic Analysis of Psychosocial Group Therapy in Women with Metastatic Breast Cancer

  • Julie Lemieux
  • Adam Topp
  • Heather Chappell
  • Marguerite Ennis
  • Pamela J. Goodwin
Clinical trial



Metastatic breast cancer is associated with psychological distress in one-third of patients. We examined the impact of group psychosocial support on health care costs in metastatic breast cancer. Psychosocial interventions have been shown to reduce psychological distress in these patients. In other diseases, depression and anxiety have been associated with higher health care system resource utilization.


Data on health care system resources utilization were collected as part of a Canadian multicenter randomized controlled trial of a supportive-expressive group support in metastatic breast cancer. Costs were obtained from one tertiary care hospital in Toronto. A cost minimization analysis was conducted since there was no survival difference; the primary endpoint of the study. Cost-effectiveness analyses were conducted for mood and pain.


Total health care utilization costs (including costs of the group therapy intervention) for the intervention and control groups were $31,715 and $28,189, respectively per patient. The difference in total costs between groups ($3,526) was not statistically significant (P = 0.53). The cost-effectiveness analysis for mood showed the intervention group to have an increased cost of $5,550 per patient for an effect size of 0.5 on the POMS scale. The corresponding cost for pain was $4,309. An exploratory analysis on patients who were more distressed at baseline showed a non-significant decrease in cost in favor of the intervention arm (difference of $3,911 P = 0.66).


Psychosocial intervention, in the form of supportive-expressive group support for metastatic breast cancer, does not lower health care system resource utilization.

Key words

Cost-effectiveness Metastatic breast cancer Psychotherapy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.



Dr. Lemieux is supported on a Canadian Institute of Health Research (CIHR)/Canadian Association of Medical Oncologists/ Rx&D Research Fellowship program and Université Laval fellowship. The research was funded by the CIHR and the Canadian Breast Cancer Research Alliance.


  1. 1.
    Institute NC (1975–2001) SEER Cancer Statistics ReviewGoogle Scholar
  2. 2.
    Canadian Cancer Statistics (2003) National Cancer Institute of Canada, Health Canada, Canadian Cancer Society, Statistics Canada, Provincial/Territorial cancer registriesGoogle Scholar
  3. 3.
    Butler LD et al (2003) Psychological distress and pain significantly increase before death in metastatic breast cancer patients. Psychosom Med 65:416–426PubMedCrossRefGoogle Scholar
  4. 4.
    Zabora J et al (2001) The prevalence of psychological distress by cancer site. Psychooncology 10:19–28PubMedCrossRefGoogle Scholar
  5. 5.
    Spiegel D et al (1981) Group support for patients with metastatic cancer. A randomized outcome study. Arch Gen Psychiatry 38:527–533PubMedGoogle Scholar
  6. 6.
    Arathuzik D (1994) Effects of cognitive-behavioral strategies on pain in cancer patients. Cancer Nurs 17:207–214PubMedGoogle Scholar
  7. 7.
    Edmonds CV et al (1999) Psychological response to long-term group therapy: a randomized trial with metastatic breast cancer patients. Psychooncology 8:74–91PubMedCrossRefGoogle Scholar
  8. 8.
    Edelman S et al (1999) A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psychooncology 8:295–305PubMedCrossRefGoogle Scholar
  9. 9.
    Classen C et al (2001) Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry 58:494–501PubMedCrossRefGoogle Scholar
  10. 10.
    Goodwin PJ et al (2001) The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 345:1719–1726PubMedCrossRefGoogle Scholar
  11. 11.
    Hawley DJ, Wolfe F (1988) Anxiety and depression in patients with rheumatoid arthritis: a prospective study of 400 patients. J Rheumatol 15:932–941PubMedGoogle Scholar
  12. 12.
    Katz PP, Yelin EH (1993) Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis. J Rheumatol 20:790–796PubMedGoogle Scholar
  13. 13.
    Vali FM, Walkup J (1998) Combined medical and psychological symptoms: impact on disability and health care utilization of patients with arthritis. Med Care 36:1073–1084PubMedCrossRefGoogle Scholar
  14. 14.
    Manning WG Jr, Wells KB (1992) The effects of psychological distress and psychological well-being on use of medical services. Med Care 30:541–553PubMedCrossRefGoogle Scholar
  15. 15.
    Roy-Byrne PP (1996) Generalized anxiety and mixed anxiety-depression: association with disability and health care utilization. J Clin Psychiatry 57(Suppl 7):86–91PubMedGoogle Scholar
  16. 16.
    Katon W et al (1990) Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry 12:355–362PubMedCrossRefGoogle Scholar
  17. 17.
    Chiles J et al (1999) The impact of psychological interventions on medical cost offset: a meta-analytic review. Clin Psychol Sci Pract 6:204–220CrossRefGoogle Scholar
  18. 18.
    Carlson LE, Bultz BD (2004) Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psychooncology 13:837–849; discussion 850–856Google Scholar
  19. 19.
    Rosenberg HJ et al (2002) Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatry Med 32:37–53PubMedCrossRefGoogle Scholar
  20. 20.
    Simpson JS et al (2001) Effect of group therapy for breast cancer on healthcare utilization. Cancer Pract 9:19–26PubMedCrossRefGoogle Scholar
  21. 21.
    Hewitt M, Herdman R, Holland J (eds) (2004) Meeting psychosocial needs of women with breast cancer, 1st edn. The National Academy Press, WashingtonGoogle Scholar
  22. 22.
    Bordeleau L et al (2003) Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data. J Clin Oncol 21:1944–1951PubMedCrossRefGoogle Scholar
  23. 23.
    Norman GR et al (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41:582–592PubMedCrossRefGoogle Scholar
  24. 24.
    Warde P, Murphy T (1996) Measuring the cost of palliative radiotherapy. Can J Oncol 6(Suppl 1):90–94PubMedGoogle Scholar
  25. 25.
    Leighl NB et al (2002) Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer. J Clin Oncol 20:1344–1352PubMedCrossRefGoogle Scholar
  26. 26.
    Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, Hillsdale, NJGoogle Scholar
  27. 27.
    Nyenhuis DL et al (1999) Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol 55:79–86PubMedCrossRefGoogle Scholar
  28. 28.
    Spiegel D et al (1989) Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2:888–891PubMedCrossRefGoogle Scholar
  29. 29.
    Edelman S et al (1999) Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology 8:474–481PubMedCrossRefGoogle Scholar
  30. 30.
    Claxton K (1999) The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 18:341–364PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2006

Authors and Affiliations

  • Julie Lemieux
    • 1
  • Adam Topp
    • 2
  • Heather Chappell
    • 3
  • Marguerite Ennis
    • 4
  • Pamela J. Goodwin
    • 1
  1. 1.Samuel Lunenfeld Research Institute of the Mount Sinai HospitalUniversity of TorontoTorontoCanada
  2. 2.Department of Health Policy Management and Evaluation (HPME)Hay Health Care Consulting Group, University of TorontoTorontoCanada
  3. 3.Department of HPMEUniversity of TorontoTorontoCanada
  4. 4.Applied StatisticianMarkham, OntarioCanada

Personalised recommendations